QuidelOrtho Corporation
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $630.9M | $619.8M | $723.6M | $699.9M | $613.9M | $692.8M | $707.8M | $727.1M |
| Cost of Revenue | $358.0M | $356.0M | $403.2M | $364.3M | $339.0M | $349.5M | $381.7M | $374.8M |
| Gross Profit | $272.9M | $263.8M | $320.4M | $335.6M | $274.9M | $343.3M | $326.1M | $352.3M |
| Gross Margin | 43.3% | 42.6% | 44.3% | 47.9% | 44.8% | 49.6% | 46.1% | 48.5% |
| Operating Expenses | ||||||||
| Research & Development | $48.7M | $44.9M | $45.8M | $41.5M | $45.7M | $53.2M | $47.3M | $55.9M |
| SG&A Expense | $189.7M | $199.3M | $194.4M | $186.9M | $178.0M | $187.0M | $187.5M | $186.4M |
| Operating Income | $-21.8M | $-31.8M | $-66.3M | $-704.8M | $-180.7M | $32.6M | $-100.4M | $15.0M |
| Operating Margin | -3.5% | -5.1% | -9.2% | -100.7% | -29.4% | 4.7% | -14.2% | 2.1% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-81.2M | $-79.5M | $-112.4M | $-756.9M | $-229.6M | $-8.8M | $-140.9M | $-28.8M |
| Income Tax Expense | $11.7M | $12.3M | $18.3M | $-23.9M | $25.8M | $3.9M | $37.5M | $-8.9M |
| Net Income | $-92.9M | $-91.8M | $-130.7M | $-733.0M | $-255.4M | $-12.7M | $-178.4M | $-19.9M |
| Net Margin | -14.7% | -14.8% | -18.1% | -104.7% | -41.6% | -1.8% | -25.2% | -2.7% |
| EPS (Basic) | $-1.36 | $-1.35 | $-1.95 | $-10.78 | $-3.77 | $-0.19 | $-2.54 | $-0.30 |
| EPS (Diluted) | $-1.36 | $-1.35 | $-1.95 | $-10.78 | $-3.77 | $-0.19 | $-2.54 | $-0.30 |
| Shares Outstanding (Basic) | 68.3M | 68.2M | 67.8M | 68.0M | 67.7M | 67.5M | 67.2M | 67.3M |
| Shares Outstanding (Diluted) | 68.3M | 68.2M | 67.8M | 68.0M | 67.7M | 67.5M | 67.2M | 67.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |